Syndax Pharmaceuticals, Inc. (SNDX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Syndax Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -6.38x | -3.55x | -7.26x | -10.35x | 45.72x | -12.57x |
| P/B Ratio | 28.16x | 3.93x | 2.74x | 3.31x | 2.79x | 3.64x |
| P/S Ratio | 10.56x | 47.80x | 0.00x | 0.00x | 8.16x | 605.60x |
| Profitability | ||||||
| Gross Margin | 96.0% | 96.5% | 0.0% | 0.0% | 100.0% | 100.0% |
| Operating Margin | -158.4% | -1434.4% | 0.0% | 0.0% | 18.8% | -4708.2% |
| Net Margin | -165.6% | -1346.1% | 0.0% | 0.0% | 17.8% | -4816.7% |
| EBITDA Margin | -146.0% | -1325.3% | 0.0% | 0.0% | 19.2% | -4633.2% |
| Liquidity | ||||||
| Current Ratio | 4.40x | 5.82x | 10.00x | 16.85x | 21.68x | 15.84x |
| Quick Ratio | 4.12x | 5.82x | 10.00x | 16.85x | 21.68x | 15.84x |
| Leverage | ||||||
| Debt/Equity | 5.36x | 1.20x | 0.00x | 0.00x | 0.05x | 0.08x |
YoY = year-over-year change. Source: FMP..